| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ZAFGEN INC COM | 3,511,456 | 56,497,000 | 33.47% | ||
| 2 | Orexigen Therapeutics, Inc. | 4,200,047 | 32,886,000 | 19.48% | ||
| 3 | EPIZYME INC COM | 754,806 | 14,175,000 | 8.40% | ||
| 4 | AUSPEX PHARMACEUTICALS INC | 75,000 | 7,520,000 | 4.46% | ||
| 5 | REGULUS THERAPEUTICS INC | 429,723 | 7,280,000 | 4.31% | ||
| 6 | AERIE PHARMACEUTICALS INC | 210,067 | 6,583,000 | 3.90% | ||
| 7 | NEXVET BIOPHARMA PUB LTD CO | 708,332 | 5,688,000 | 3.37% | ||
| 8 | JUNO THERAPEUTICS INCORPORATED | 91,575 | 5,555,000 | 3.29% | ||
| 9 | QUOTIENT LTD | 326,509 | 5,551,000 | 3.29% | ||
| 10 | SCYNEXIS INC | 662,945 | 5,502,000 | 3.26% | ||
| 11 | BioDelivery Sciences International Inc | 447,878 | 4,703,000 | 2.79% | ||
| 12 | Alder Biopharmaceutl | 157,131 | 4,535,000 | 2.69% | ||
| 13 | Agile Therapeutics, Inc. | 459,266 | 4,257,000 | 2.52% | ||
| 14 | T2 BIOSYSTEMS INC | 233,019 | 3,616,000 | 2.14% | ||
| 15 | SANGAMO BIOSCIENCES INCORPORATED | 165,000 | 2,587,000 | 1.53% | ||
| 16 | IGNYTA INC COM | 185,220 | 1,843,000 | 1.09% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-027507, filed 2015.05.05).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
